CAITLIN MULLIGAN: Open Payments
NPI 1285164814 · CHELSEA, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 12 payments from 4 companies in 2025. Trend: 2023 $232 · 2024 $255 · 2025 $823
Food & beverage: $711Education: $81Travel & lodging: $30
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $371 |
| Teva Pharmaceuticals USA, Inc. | 5 | $206 |
| Neurocrine BioSciences, Inc. | 2 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
Products named: COBENFY, UZEDY, CAPLYTA, AUSTEDO XR.
Industry payments across MA — which companies pay providers there.
